|COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring.|
Challenges in Building a Genomic Prescribing System
If you have a question about this talk, please contact wattpa.
The implementation of pharmacogenomic knowledge has been slow, and the pace of such implementation has been disappointing to many. The barriers to implementation are multiple, and include scientific, financial, and technical barriers. Although the quantity of scientific publications in pharmacogenomics is increasing at an exponential rate, the quality of such publications is highly variable, challenging standard approaches to meta-analysis. Furthermore, most investigators have focused on common –rather than rare –variants. Financial barriers include the high expense of genotyping relative to standard laboratory tests, further complicated by limited intellectual property protection for pharmacogenomic tests. Technical barriers include physician knowledge, as well as time delays in obtaining results. One possible implementation solution is a genomic prescribing system, such as the one in development at the University of Chicago (http://cpt.uchicago.edu/page/genomic-prescribing-system-gps).
This talk is part of the Cancer Research UK Cambridge Institute Seminars in Cancer series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
Other listsMordell Lectures Clare College Graduate Research Forum Religion and the Idea of a Research University
Other talksGeographical perspectives on personality and wellbeing Strategic Bidding in Multi-unit Auctions with Capacity Constrained Bidders: The New York Capacity Market Tipping Points in Social, Economic and Biological Systems Under the bonnet of the Ferrari of the virus world - Norovirus replication and immune evasion Sonic Pi: Teaching Computer Science with Music Object handling session